|
Status |
Public on Mar 23, 2012 |
Title |
RIT5_6MOS_SD0507B |
Sample type |
RNA |
|
|
Channel 1 |
Source name |
RIT5_6MOS_B, Rituximab Patient tissue
|
Organism |
Homo sapiens |
Characteristics |
biopsy: skin
|
Biomaterial provider |
Robert Lafyatis, Boston University
|
Treatment protocol |
3 - 6 mm punch biopsy stored in RNA later
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA extract using Qiagen Rneasy Tissuekit
|
Label |
Cy3
|
Label protocol |
Agilent Low RNA Input Linear Amplification protocol: 100 ng of total RNA from each biopsy was converted to Cy3-CTP (Perkin Elmer) labeled cRNA, and Universal Human Reference (UHR) RNA (Stratagene) was converted to Cy5-CTP (Perkin Elmer) using a low input linear amplification kit (Agilent Technologies) as per manufacturers protocols. Labeled cRNA targets were then purified using RNeasy columns (Qiagen).
|
|
|
Channel 2 |
Source name |
Universal Human Reference
|
Organism |
Homo sapiens |
Characteristics |
reference: Stratagene's Universal Human Reference (RNA pool from 10 different human cell lines; http://www.ncbi.nlm.nih.gov/pubmed/15113400)
|
Biomaterial provider |
Stratagene
|
Treatment protocol |
none
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA isolated by stratagene
|
Label |
Cy5
|
Label protocol |
Agilent Low RNA Input Linear Amplification protocol: 100 ng of total RNA from each biopsy was converted to Cy3-CTP (Perkin Elmer) labeled cRNA, and Universal Human Reference (UHR) RNA (Stratagene) was converted to Cy5-CTP (Perkin Elmer) using a low input linear amplification kit (Agilent Technologies) as per manufacturers protocols. Labeled cRNA targets were then purified using RNeasy columns (Qiagen).
|
|
|
|
Hybridization protocol |
Agilent Gene Expression Hybridization kit was used for hybridization. Cy3- and Cy5-labeled cRNA was hybridized to Agilent Whole Human genome oligo-array. Hybridization was carried out for 17 hours at 65oC with rotation.
|
Scan protocol |
Fluorescent array images were collected for both Cy3 and Cy5 with a GenePix 4000B fluorescent scanner and image intensity data were extracted and analyzed with GenePix Pro 5.0 analysis software.
|
Description |
RIT5_6MOS_B, Rituximab Patient tissue
|
Data processing |
Data for both channels were lowess-normalized and then log(2) ratio was taken. As for lowess program, we download from BASE.
|
|
|
Submission date |
Sep 26, 2011 |
Last update date |
Jun 13, 2017 |
Contact name |
Tammara Wood |
E-mail(s) |
[email protected]
|
Organization name |
Dartmouth Medical School
|
Department |
Biomedical Data Science
|
Lab |
Whitfield Lab
|
Street address |
WTRB 674
|
City |
Lebanon |
State/province |
NH |
ZIP/Postal code |
03756 |
Country |
USA |
|
|
Platform ID |
GPL4133 |
Series (2) |
GSE32413 |
Stable gene expression of serial skin biopsies defines patient subsets in diffuse cutaneous systemic sclerosis |
GSE76809 |
Multi-tissue functional genomic study of systemic sclerosis |
|
Relations |
Reanalyzed by |
GSE56308 |
Data table header descriptions |
ID_REF |
Spot Reference ID |
VALUE |
log2_ratio of CH2DL_MEAN over CH1DL_MEAN (LOG_RAT2L_MEAN) |
SPOT |
spot number on array |
CH1_MEAN |
|
CH1_SD |
standard deviation of channel 1 intensity |
CH1_BKD_MEDIAN |
channel 1 background median intensity |
CH1_BKD_SD |
standard deviation of channel 1 background median intensity |
CH2_MEAN |
channel 2 mean intensity |
CH2_SD |
standard deviation of channel 2 intensity |
CH2_BKD_MEDIAN |
channel 2 background median intensity |
CH2_BKD_SD |
standard deviation of channel 2 background median intensity |
TOT_BPIX |
number of background pixels |
TOT_SPIX |
number of spot pixels |
CH2BN_MEDIAN |
channel 2 normalized background median intensity |
CH2IN_MEAN |
channel 2 normalized mean intensity |
CH1DL_MEAN |
channel 1 Lowess_normalized mean intensity |
CH2DL_MEAN |
channel 2 Lowess_normalized mean intensity |
LOG_RAT2N_MEAN |
log2_ratio of channel 2 normalized over channel 1 (global normalization) |
CORR |
correlation coefficient among pixels |
FLAG |
Spot flag. 0:not flagged; negative:flagged as bad spots; positive:flagged as good spots |